Navigation Links
Dr. Daniel Ronel Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

SANTA FE and ALBUQUERQUE, N.M., July 10 /PRNewswire/ -- Daniel Ronel, M.D., a board-certified plastic surgeon, has selected Artefill, the first and only FDA-approved microsphere-enhanced collagen filler for the correction of smile lines, to treat patients who are looking for a longer lasting dermal filler. Dr. Ronel has been an avid Artefill user the past several years due to its proven success and effectiveness for the correction of wrinkles.

He says, "My patients love the fact that their wrinkle correction can last for years with Artefill, and I enjoy using it because it is silky smooth, versatile, and clear. In this economy, people are grateful that they do not need to come back repeatedly to pay for more filler! I have found that each syringe of Artefill goes a long way."

This simple, in-office procedure takes approximately fifteen minutes to complete. A patient is injected with Artefill similar to other dermal fillers with the key difference being its lasting effect. The unique microspheres in Artefill are not absorbed by the body and therefore provide the support the skin needs for long lasting natural feeling results. This is different from temporary dermal fillers that are made of different kinds of natural or synthetic materials that are completely absorbed by the body over time and require repeat injections to maintain wrinkle correction. A skin test is required prior to treatment or approximately four (4) weeks ahead of time, to ensure a patient is not allergic to the collagen or anesthetic in Artefill.

Artefill is only offered by a select group of physicians in the Southwest and is not available at all physician offices. Dr. Ronel is one of the company trained and select few company sponsored physicians who has the skills and experience needed to administer the product.

Elizabeth Ferrell, a patient of Dr. Ronel's said, "Artefill was the logical choice for me -- I've had deep lines ever since I was a teenager and I was frustrated at having to go back and forth for more injections. Dr. Ronel's technique, with all the holistic things he does, actually made the whole experience pleasant. My family and friends were very impressed, and felt the same way after they went in themselves."

About Artefill:

Artefill is the first and only FDA-approved microsphere-enhanced collagen filler for the correction of nasolabial folds, better known as smile lines. The safety and effectiveness of Artefill has been extensively studied over the past eight years. Since Artefill was approved in 2006, over 10 thousand patients have been treated successfully with very high satisfaction rates.

Suneva Medical, Inc., a medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets, markets and manufactures Artefill. The Company was formed in April 2009 to deliver the same great product that physicians and patients have embraced over the past several years. For more information visit or

DR. DANIEL RONEL is a board-certified plastic surgeon with offices in Santa Fe and Albuquerque NM. Educated and trained at Princeton, Penn, Columbia, Cornell, and Harvard, he is the only surgeon in the U.S. who is board certified in both plastic surgery and pediatrics. Dr. Ronel was named one of America's Top Plastic Surgeons by the Consumer's Research Council of America. Because of his combined expertise in pediatrics and plastic surgery, Dr. Ronel is one of 13 national experts selected by Allergan to sit on the Breast Implant Research Team, an advisory panel on silicone breast implants. Dr. Ronel is a member of the Radiesse Medical Education Facility, a group composed of approximately 120 physicians from across the United States who are experts in the field of injectable fillers. He was voted Albuquerque's Plastic Surgeon of the Year in 2007 by readers of The Herald, and was named one of Albuquerque's 2007 Top Docs by Albuquerque, the Magazine. He can be found on the web at

ATTENTION MEDIA: To download Artefill patient before and after pictures visit

    Daniel Ronel, M.D.
    Office: 505-982-2440
    Cell: 505-690-5337

SOURCE Daniel Ronel, M.D.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. PPD Names Daniel Darazsdi as Chief Financial Officer
3. OmniSonics Appoints J. Daniel Cole Chairman of the Board
4. Corium International, Inc. Announces Appointment of Phyllis Gardner, M.D. and Daniel G. Welch to Board
5. Ikaria Appoints Daniel Tasse as President and Chief Executive Officer
6. CNS Response, Inc Completes Neuro-Therapy Clinic Acquisition; Names Daniel A. Hoffman, MD Chief Medical Officer
7. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors
8. Anesiva Appoints Daniel Janney to Board of Directors
9. Egenix, Inc. Appoints Dr. Daniel Petrylak Chairman of Scientific Advisory Board
10. Daniel B. Dubin, M.D., Joins NanoBio Corp.s Board of Directors
11. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
Post Your Comments:
(Date:6/27/2016)... June 27, 2016   Ginkgo Bioworks , a ... engineering, was today awarded as one of the ... the world,s most innovative companies. Ginkgo Bioworks is ... the real world in the nutrition, health and ... directly with customers including Fortune 500 companies to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... ) The integration will ... to access and transact across channels. Using this ...
Breaking Biology News(10 mins):